National HealthCare Corporation

NHC Healthcare Medical Care Facilities

National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.

Revenue
+6.61%
EPS
−65.6%
Free cash flow
+75.5%
Total debt
+216.7%

Quarter to September 2026, against a year earlier

207.47 4.93 −2.32%
Market cap
$3.3B
P/E
28.2×
Fwd P/E
8.4×
Dividend yield
1.26%
F-score
7/9
Altman Z
5.02
Beneish M
−2.57
Dividend safety
74/100

National HealthCare Corporation (NHC) EBITDA

Alert me on EBITDA

National HealthCare Corporation's EBITDA for fiscal 2025 was $173.3M, up 31.4% from $131.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was $190.4M. Over the past ten years it has ranged from $78.9M (fiscal 2022) to $173.3M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. National HealthCare Corporation ranks 23rd of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $173.3M 31.39%
FY2024 $131.9M 32.55%
FY2023 $99.5M 26.03%
FY2022 $78.9M (14.60%)
FY2021 $92.4M 0.95%
FY2020 $91.6M (3.19%)
FY2019 $94.6M (7.87%)
FY2018 $102.7M 1.00%
FY2017 $101.7M (1.79%)
FY2016 $103.5M (3.13%)

Quarterly newest first

Period EBITDA Change
Jun 2026 $60.1M 37.02%
Mar 2026 $43.9M (2.27%)
Dec 2025 $44.9M 8.07%
Sep 2025 $41.5M (7.91%)
42 more quarters

Against its own ten years

Low $78.9M High $173.3M
Ten-year median $101.7M
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on NHC